Novel small molecule HSP90 inhibitor for the management of atopic dermatitis
Ended Project Grant Awarded Last action
- Award ID
- R43AR077503
- Recipient
-
Regranion, LLC UEI MC1LNCYZJCK9
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $252,131
Award facts
- Assistance listing
- 93.846 Arthritis, Musculoskeletal and Skin Diseases Research
- Completion date
- Originally
- Place of performance
- South Carolina, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $252,131 |
Quick answers
Who received award R43AR077503?
R43AR077503 was awarded to Regranion, LLC by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on September 15, 2020.
How much is award R43AR077503 worth?
$252,131 has been obligated on R43AR077503.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award